Susan G. Komen
Registered Principal Details
Business Or Interest:
Komen works to eliminate the most deadly and aggressive forms of breast cancer, while also addressing systemic barriers to equitable care for all.
Lobbying Interests:
Budget and health care related legislation impacting the breast community.
Title:
Director, State Policy & Advocacy
Komen works to eliminate the most deadly and aggressive forms of breast cancer, while also addressing systemic barriers to equitable care for all.
Lobbying Interests:
Budget and health care related legislation impacting the breast community.
Title:
Director, State Policy & Advocacy
Contact
RB
Rebecca Birch
13770 Noel Rd., Suite 801889
Dallas, TX 75380
(972) 701-2037
rbirch@komen.org
http://www.komen.org
13770 Noel Rd., Suite 801889
Dallas, TX 75380
(972) 701-2037
rbirch@komen.org
http://www.komen.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Dana Carter | Exclusive Duties Yes | Authorized On 1/18/2022 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
1/24/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date1/24/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 745
Relating to: prohibiting step therapy protocols for certain cancer drugs.
Bill Text and History
1/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting step therapy protocols for certain cancer drugs.
Bill Text and History
For
Notification Date1/19/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 747
Relating to: coverage of infertility services under health policies and plans and granting rule-making authority.
Bill Text and History
1/27/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: coverage of infertility services under health policies and plans and granting rule-making authority.
Bill Text and History
For
Notification Date1/27/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|
| Total Lobbying Expenditures | 2022 January - June $358.44 |
2022 July - December $0.00 |
Total $358.44 |
| Total Hours Communicating | 2022 January - June 1.25 |
2022 July - December 0.00 |
Total 1.25 |
| Total Hours Other | 2022 January - June 6.50 |
2022 July - December 0.00 |
Total 6.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 16% |
2022 July - December |
Total 13% |
Relating to: coverage of infertility services under health policies and plans and granting rule-making authority.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 26% |
2022 July - December |
Total 26% |
Relating to: prohibiting step therapy protocols for certain cancer drugs.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 58% |
2022 July - December |
Total 52% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.